;

Auto Summaries - Immunology
Last updated: 2025 Jun 18
Total hit(s): 28254
S.No.
1
39794268
Controlling the COVID-19 pandemic through vaccination: a perspective from Indonesia.
N/A
Expert Rev Vaccines
2025 Dec
4.37
1
2
39957551
Reply to the letter to the editor: previous immunological disease can promote neurological complications of SARS-CoV-2 infection, such as VST or GBS.
N/A
Future Sci OA
2025 Dec
3.25
1
3
39927642
Previous immunological disease can promote neurological complications of SARS-CoV-2 infection, such as VST or GBS.
N/A
Future Sci OA
2025 Dec
3.25
1
4
40494727
Mandatory vaccination against COVID-19 and Influenza for ICU personnel? Yes!
N/A
Intensive Crit Care Nurs
2025 Jun 9
1.85
1
5
40489310
FDA Review of Novavax's COVID-19 Vaccine-Regulatory Integrity and Deviations From Standard Practice.
N/A
JAMA
2025 Jun 9
14.78
1
6
40484765
Mandatory vaccination against COVID-19 and Influenza for ICU personnel? No!
N/A
Intensive Crit Care Nurs
2025 Jun 7
1.85
1
7
40459240
Differentiating SARS-CoV-2 antibody responses between infection and vaccination: challenges for epidemiological research.
N/A
J Infect Dis
2025 Jun 3
4.73
1
8
40461181
Trump watch: Confusion over covid-19 vaccination, HIV vaccine funding withdrawn, and more.
N/A
BMJ
2025 Jun 3
30.22
1
9
40466805
Letters to the Editor: Uptake and Factors Associated with COVID-19 Vaccination Among 3,779,733 Adults Living With and Without Diabetes: A Population Cohort Study in a Universal Health Care Setting.
N/A
Can J Diabetes
2025 Jun 2
2.4
1
10
40523536
Vaccination equity: a warning from the COVID-19 pandemic.
N/A
Brain Behav Immun
2025 Jun 14
6.13
1
11
40516004
Time preferences and COVID-19 vaccination uptake.
N/A
Eur J Health Econ
2025 Jun 14
5.2
1
12
40516303
Corrigendum to "Healthcare provider recommendations for COVID-19 vaccination: Prevalence, disparities, and correlates" [Patient Educ Couns 130 (2025) 108481].
N/A
Patient Educ Couns
2025 Jun 13
4.3
1
13
40522018
Lofgren's Syndrome Following BNT162b2 mRNA COVID-19 Vaccination and Subsequent Plaque-type Cutaneous Sarcoidosis after its Resolution.
N/A
Acta Derm Venereol
2025 Jun 12
3.01
1
14
40500375
Author Correction: Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2.
N/A
Sci Rep
2025 Jun 11
4.12
1
15
40444914
Airway Immune Signatures in Severe and Fatal Infection with COVID-19.
N/A
Am J Respir Cell Mol Biol
2025 Jun
3.94
1
16
40296611
Corrigendum to Exploring COVID-19 Vaccine Hesitancy Among Stakeholders in African American and Latinx Communities in the Deep South Through the Lens of the Health Belief Model.
N/A
Am J Health Promot
2025 Jun
1.83
1
17
40457064
Mutated epitopes in SARS-CoV-2 variants are poorly immunogenic.
N/A
Nat Immunol
2025 Jun
18.5
1
18
40382019
Letter to the editor on "Advanced photohydrolysis technology demonstrates rapid inactivation of aerosolized SARS-CoV-2 and efficacy against other respiratory viral pathogens".
N/A
Am J Infect Control
2025 Jun
2.03
1
19
40476809
Integrating Bioethics and Science Communication Insights to Promote Translational Justice, Critical Consciousness, and Global Health Equity in COVID-19 Vaccination.
N/A
Am J Bioeth
2025 Jun
4.84
1
20
40104250
A Canadian multi-province study of COVID-19 vaccine coverage along area-level social determinants in 2021.
N/A
Public Health Pract (Oxf)
2025 Jun
3.4
1
21
40326839
A letter to the editor in response to: indirect comparison of the relative vaccine effectiveness of mRNA-1283 vs. BNT162b2 vaccines against symptomatic COVID-19 among US adults.
N/A
Curr Med Res Opin
2025 May 9
2.22
1
22
40343624
Correction: Routine vaccination coverage at ages 2 and 7, before, during, and after the COVID-19 pandemic: Results from the STARVAX surveillance system.
N/A
Can J Public Health
2025 May 9
2.3
1
23
40343968
Securitising science: the COVID-19 crisis and vaccine politics in Iran.
N/A
Infect Dis (Lond)
2025 May 9
1.23
1
24
40327102
Correction: Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study.
N/A
Med Microbiol Immunol
2025 May 6
6.7
1
25
40327046
Correction to: Relative Effectiveness and Waning of a Third Dose of mRNA COVID-19 Vaccine in Medicare Beneficiaries Aged 65 Years and Older during the BA.1/BA.2 Omicron Period.
N/A
J Infect Dis
2025 May 6
4.73
1